Evidence map›Paper›PMID 31611817›Full record

ArticleFrontiers in physiology2019

EP3 Blockade Adds to the Effect of TP Deficiency in Alleviating Endothelial Dysfunction in Atherosclerotic Mouse Aortas.

Chuangjia Hu, Bin Liu, Yineng Xu, Xiangzhong Wu, Tingting Guo, Yingzhan Zhang, Jing Leng, Jiahui Ge, Gang Yu, Jinwei Guo and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Chuangjia HuDepartment of Cardiology, First Affiliated Hospital, Shantou University Medical College, Shantou, China.
Bin LiuCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Yineng XuCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Xiangzhong WuCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Tingting GuoCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Yingzhan ZhangCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Jing LengCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Jiahui GeCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Gang YuCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Jinwei GuoCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Yingbi ZhouCardiovascular Research Center, Shantou University Medical College, Shantou, China.
Shantou University Medical College · CNShantou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial dysfunction, which leads to ischemic events under atherosclerotic conditions, can be attenuated by antagonizing the thromboxane-prostanoid receptor (TP) that mediates the vasoconstrictor effect of prostanoids including prostacyclin (PGI

Indexed as

atherosclerosiscontractionendotheliumPGI2prostanoid receptorsrelaxation

Identifiers

PMID31611817
PMCPMC6775864
OpenAlexW2975994050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.